Press Releases
June 15, 2018
Lexington, Mass.
May 09, 2018
Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the first quarter 2018.
Business Wire | May 02, 2018
Lexington, Mass.
Business Wire | April 27, 2018
LEXINGTON, Mass.--(BUSINESS WIRE)--
Business Wire | March 21, 2018
Lexington, Mass.
Business Wire | March 20, 2018
Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity
Business Wire | March 14, 2018
Revenue at high end of range previously provided
Successful IPO completed in December 2017
Launch of SR-X in Q4, earlier than planned
Business Wire | March 08, 2018
Research presented at Conference on Retroviruses and Opportunistic Infections (CROI) validates platform’s advanced detection capabilities and demonstrates potential to detect the infection at pre-symptomatic stages
Business Wire | March 07, 2018
Quanterix announced that it will release its financial results for fourth quarter and fiscal year 2017 after the close of trading on Wednesday, March 14, 2018.
Business Wire | March 07, 2018
Kevin Hrusovsky, Chief Executive Officer, President and Chairman of Quanterix, will present at the Cowen and Company 38th Annual Healthcare Conference, on Monday, March 12, 2018 at 4:50 p.m., EST at the Boston Marriott Copley Place.